Show Summary Details
Page of

Management of tachyarrhythmias 

Management of tachyarrhythmias
Management of tachyarrhythmias

James L. Harrison

and Mark D. O’Neill

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 May 2022

The process of ageing is associated with an increased incidence of cardiac tachyarrhythmias, which are responsible for significant morbidity and mortality. Structural and functional changes, both mechanical and electrical, occur in the ageing heart, together with alterations in cardiac energetics and metabolism. However, the molecular mechanisms underlying tachyarrhythmias are not fully understood and there is a lack of evidence to guide treatments in older adults. Ventricular tachyarrhythmias are a major cause of unexpected death in older adults, especially in people with coronary artery disease. Sudden cardiac death is responsible for 13% of all natural deaths and 50% of cardiovascular deaths in older adults. The prevalence of asymptomatic and symptomatic supraventricular tachycardias also increases with age. With careful consideration of risks and benefits, age should not be seen as a contraindication to invasive device or ablation therapy for cardiac tachyarrhythmias.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.